Study Purpose: This study aims to check if taking Lu AG09222 with ubrogepant is safe for people with migraines. *Migraines* are intense headaches that can cause throbbing pain, often on one side of the head. *Ubrogepant* is a tablet that helps relieve migraine pain, while *Lu AG09222* is given as an injection. Some participants will receive a placebo, which is a harmless injection without medicine, to compare results. Eligibility: To join, you need to have had migraines for at least a year and have 2-14 migraine days per month. You should not have used certain migraine treatments or participated in other studies recently. Pregnant women or those planning to become pregnant are not eligible.

• Length of Study: Participation requires multiple visits over a few months.
• Treatment: You might receive the actual medicine or a placebo.
• Risks and Safety: The study will monitor for any new or worsening health issues.

This study helps researchers understand if combining these treatments is safe and effective for migraine sufferers. If you meet the criteria and are interested, you may consider joining after consulting with your doctor.